TipRanks
Go Ultimate55% OFF

Veraxa Biotech (VRXA) Income Statement

Veraxa Biotech Income Statement

Last quarter (Q1 2026), Veraxa Biotech's total revenue was $0.00. In Q1, Veraxa Biotech's net income was $180.50K. See Veraxa Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24
$ 0.00$ 0.00
$ 0.00$ 0.00
$ 1.79M$ 702.96K
Depreciation and Amortization$ 0.00$ 0.00
$ -1.79M$ -702.96K
$ -1.79M$ -702.96K
$ 10.77M$ 4.84M
$ 8.99M$ 4.14M
$ 8.99M$ 4.14M
Per Share Metrics
Basic EPS$ 0.36$ 0.15
Diluted EPS$ 0.36$ 0.15
Weighted Average Shares Outstanding25.30M26.73M
Weighted Average Shares Outstanding (Diluted)25.30M26.73M

Currency in USD

Veraxa Biotech Earnings and Revenue History

04M8M12M0 %0.4 %0.8 %1.2 %EarningsProfit Margin20242025RevenueEarningsProfit Margin